Tweet

NPHCDA

11 Mar, 10 tweets, 2 min read

Press Statement on concerns about the safety of the Oxford/AstraZeneca Vaccine.

We are aware of precautionary concerns that have been raised regarding one specific batch of the AstraZeneca vaccine, namely ABV5300.

We understand that investigations are being conducted to determine if the batch is in any way linked to an observed side effect.

While we await the outcome of the investigations, it is important to clearly state that Nigeria did not receive any doses from the batch of vaccines which is at issue.

Vaccinations in Nigeria started earlier this month and we have not observed any similar adverse reactions. All side effects reported by those who have been administered the vaccine have been mild.

We are satisfied that the clinical evidence indicates the Oxford-AstraZeneca vaccine to be safe and effective.

Our assessment is in line with countries such as Spain and the UK who have indicated that they will continue to administer the vaccine, because it remains an important tool to protect against COVID-19.

The safety of vaccines delivered to Nigeria is paramount to the Presidential Task Force on COVID-19. For this reason, it has enhanced multi-sectoral collaboration among stakeholders and technical entities such as the FMOH, NPHCDA, NAFDAC, WHO and UNICEF

whose cooperation ensures the highest global standards are met for vaccines delivered to Nigeria before they are distributed to Nigerians. Clear, rigorous protocols are being followed to safeguard the health of Nigerians.

We are continuing to monitor the developments regarding ABV5300 batch and will share further information as it becomes available.

In the meantime, we encourage Nigerians who are among those being prioritized in the current phase to continue their confidence and enthusiasm for our vitally important national vaccine program. Together, we can save lives.

#YesToCOVID19Vaccine

• • •

Missing some Tweet in this thread? You can try to force a refresh

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @NphcdaNG

NPHCDA

@NphcdaNG

10 Mar

We have answers to some questions you may have around e-REGISTRATION for #COVID19 Vaccination.

#YesToCOVID19Vaccine

To register for the #COVID19Vaccine 👇👇👇

How to register? Easy! Look below 👇

Read 11 tweets

NPHCDA

@NphcdaNG

2 Jan

As we look forward to a healthier, brighter 2021, we are excited to share key information about the #COVID19Nigeria vaccine.
Come with us.

COVID-19 is the infectious disease caused by the most recently discovered coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019.

The most common symptoms of COVID-19 are fever, tiredness, dry cough, and difficulty in breathing. Some patients may have body aches and pains, loss of smell, nasal congestion, runny nose, sore throat, or diarrhea.

Read 16 tweets

NPHCDA

@NphcdaNG

8 Nov 20

PSA: FEDERAL GOVERNMENT RESPONSE TO THE DELTA STATE YELLOW FEVER OUTBREAK IN COLLABORATION WITH THE STATE GOVERNMENT AND PARTNERS.

On 30th October 2020, an outbreak of a mysterious illness was reported from Idumesah ward, Ika North East LGA of Delta state, south south, Nigeria. Idumesah, Ute-Okpu and Owa Oyigbo wards are the most affected of the seven (7) wards in the LGA that have recorded cases.

Date of onset of the first illness was 24th July, second reported case was 29th July and third was 23rd September, 2020.

Read 20 tweets

NPHCDA

@NphcdaNG

14 Nov 19

PRESS RELEASE

INTRODUCING MEASLES SECOND DOSE AT 15 MONTHS INTO THE ROUTINE IMMUNIZATION SCHEDULE

Dear Nigerians.

From the 14th of November 2019, the Federal Government will be introducing Measles Second Dose at 15 Months into the Routine Immunization schedule.

Apart from the usual first dose of Measles at nine (9) months old, all children will be vaccinated at 15 months with a SECOND DOSE of Measles vaccine.

The SECOND DOSE of Measles vaccination is given to every child at 15 months as a second opportunity to fully protect children against the deadly Measles disease.

Read 8 tweets

NPHCDA

@NphcdaNG

29 Oct 19

The NPHCDA is introducing a SECOND DOSE of measles vaccine into the routine immunization (RI) programme. This intervention is primarily aimed at providing a second dose of measles vaccine to the children who are highly susceptible to measles.

In addition,it offers an opportunity to initiate 1st dose measles vaccination for children who might have missed in their 1st year of life or failed to seroconvert & provides an opportunity to integrate other services with immunization during the 2nd year of life for the children

Measles is an acute & highly infectious disease caused by the measles virus. It is one of the leading causes of morbidity & mortality among children under years old. Globally, an estimated 246 children die each day from measles, the majority of whom are from Africa, including 🇳🇬

Read 4 tweets

NPHCDA

@NphcdaNG

26 May 19

As part of FG commitment to implement the Basic Health Care Provision Fund (BHCPF), the sum of N55b representing 1% consolidated federal revenue was appropriated in 2018 budget and the sum of N12.7b released so far for implementation.

Of the amount available in the BHCPF, 45% is to be channeled by the NPHCDA i.e. the NPHCDA Gateway to at least ONE eligible PHC facility per geopolitical ward through the SPHCB.

On the 20th of May, 2019, the NPHCDA TSA Account was credited with N5.89b representing 45% of 12.7b. for implementation in 19 states which had been cleared for participation by the National Steering Committee of the BHCPF.

Read 7 tweets

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!